Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +72.5% | +96.4% | 3 / 3 | -44.1% | +0.73 pp | +0.50 pp | +1.0% | 0.67 | 29.98 | 1.052 | −44,1% | 8,3 | +55,5% | 29.98 | 96.36 | −68,9% |
| Pts | 12 | 12 | 12 | 0 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 3.230 (close price on 2026-10-19)EPS (TTM): 107,7
Financial charts
1.Revenue & growth
VND bn1.052Q2/26
1.Revenue & growth
VND bn1.052Q2/26
2.Profit & growth
VND bn8,57Q2/26
3.Profit mix (Penman)
VND bn11,6Q2/26
4.Margins & cost structure
%3.7%Q2/26
5.Returns & cash cycle
% · days3.5%Q2/26
6.Earnings quality & cash
VND bn471Q2/26
7.Asset structure
VND bn2.473Q2/26
8.Funding & debt health
VND bn · times2.473Q2/26
9.Revenue backlog
VND bn14,9Q2/26
10.Valuation
times · %30,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %76Q2/26
Adjusted EPS growth, latest quarter
72.5%
Average adjusted EPS growth, 3 quarters
96.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26